Literature DB >> 17403638

[Significance of dehydroepiandrosterone and dehydroepiandrosterone sulfate in different diseases].

Krisztián Bácsi1, János Kósa, Aron Lazáry, Henrik Horváth, Bernadett Balla, Péter Lakatos, Gábor Speer.   

Abstract

Dehydroepiandrosterone and dehydroepiandrosterone-sulfate are precursors of androgens and estrogens, support the gonadal sexual steroid production. The levels of dehydroepiandrosterone and dehydroepiandrosterone-sulfate are maximal between the ages of 20 and 30 years, then start a decline of 2% per year, leaving a residual of 10-20% of the peak production by the eight decade of life. The age-associated decrease may lead to osteoporosis, deterioration of lipid-metabolism, cardiovascular diseases and second type of diabetes mellitus. Decreased levels were found in autoimmune diseases and in sexual dysfunction, too. Intracrinology describes the formation of active hormones which exert their action in the same cells where synthesis took place without release into the pericellular compartment. The high local androgen and estrogen concentration may be important in the pathomechanism of hirsutism, acne, seborrhea, breast and prostate cancer. Administration of dehydroepiandrosterone resulted in a reduction of postmenopausal osteoporosis, also the decreased symptoms in systemic lupus erythematosis, psychiatric diseases and sexual disfunction. The authors summarize the metabolism of dehydroepiandrosterone and dehydroepiandrosterone-sulfate and their role in different diseases.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17403638     DOI: 10.1556/OH.2007.27903

Source DB:  PubMed          Journal:  Orv Hetil        ISSN: 0030-6002            Impact factor:   0.540


  5 in total

1.  Dehydroepiandrosterone protects against hepatic glycolipid metabolic disorder and insulin resistance induced by high fat via activation of AMPK-PGC-1α-NRF-1 and IRS1-AKT-GLUT2 signaling pathways.

Authors:  Longlong Li; Yao Yao; Jinlong Zhao; Ji Cao; Haitian Ma
Journal:  Int J Obes (Lond)       Date:  2020-01-07       Impact factor: 5.095

2.  Ample Evidence: Dehydroepiandrosterone (DHEA) Conversion into Activated Steroid Hormones Occurs in Adrenal and Ovary in Female Rat.

Authors:  Yingqiao Zhou; Jian Kang; Di Chen; Ningning Han; Haitian Ma
Journal:  PLoS One       Date:  2015-05-11       Impact factor: 3.240

3.  Dehydroepiandrosterone sulfate as a risk factor for premature myocardial infarction: a comparative study.

Authors:  Mohammad Shojaie; Mohammad Yaghoub Rajpout; Armin Abtahian; Azadeh Esmail Pour; Mohamed Amin Ghobadifar; Armin Akbarzadeh
Journal:  Korean J Fam Med       Date:  2015-01-31

4.  Long-Term Administration of Dehydroepiandrosterone Accelerates Glucose Catabolism via Activation of PI3K/Akt-PFK-2 Signaling Pathway in Rats Fed a High-Fat Diet.

Authors:  Jian Kang; Chongyang Ge; Lei Yu; Longlong Li; Haitian Ma
Journal:  PLoS One       Date:  2016-07-13       Impact factor: 3.240

5.  Dehydroepiandrosterone Prevents H2O2-Induced BRL-3A Cell Oxidative Damage through Activation of PI3K/Akt Pathways rather than MAPK Pathways.

Authors:  Longlong Li; Yao Yao; Zhihao Jiang; Jinlong Zhao; Ji Cao; Haitian Ma
Journal:  Oxid Med Cell Longev       Date:  2019-04-28       Impact factor: 6.543

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.